Allelic loss on chromosome 13q in human prostate carcinoma

Clinical Cancer Research

Volumn 3, Issue 10, 1997, Pages 1867-1872

  Melamed, Jonathan ^a   Einhorn, Jack M ^b   Ittmann, Michael M ^a,b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 13Q; CHROMOSOME LOSS; GENE LOCUS; GENETIC LINKAGE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TUMOR SUPPRESSOR GENE;

ALLELES; BRCA2 PROTEIN; CARCINOMA; CHROMOSOMES, HUMAN, PAIR 13; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0030844906     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Visakorpi, T., Kallioniemi, A., Syvanen, A., Hyytinen, E., Karhu, R., Tammela, T., Isola, J., and Kallioniemi, O. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55; 342-347, 1995.
2. Carter, B., Ewing, C., Ward, W., Treiger, B., Aalders, T., Schalken, J., Epstein, J., and Issacs, W. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
3. Ittmann, M. Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res., 56: 2143-2147, 1996.
4. Ittmann, M., and Wieczorek, R. Alterations of the retinoblastoma gene in clinically localized, Stage B prostate adenocarcinomas. Hum. Pathol., 27: 28-34, 1996.
5. Brooks, J., Bova, S., and Issacs, W. Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinoma. Prostate, 26: 35-39, 1995.
6. Phillips, S., Barton, C., Lee, S., Morton, D., Wallace, D., Lemoine, N., and Neoptolemos, J. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent early event in prostate tumorigenesis. Br. J. Cancer, 70: 1252-1257, 1994.
7. Latil, A., Cussenot, O., Fournier, G., and Lidereau, R. The BRCA-2 gene is not relevant to sporadic prostate tumors. Int. J. Cancer, 66: 282-283, 1996.
8. Bookstein, R., Rio, P., Madreperla, S., Hong, F., Allred, C., Grizzle, W., and Lee, W. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA, 87: 7762-7766, 1990.
9. Cooney, K., Wetzel, J., Merajver, S., Macoska, J., Singleton, T. and Wojno, K. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res., 56: 1142-1145, 1996.
10. Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., Kitamura, H., and Shuin, T, Retinoblastoma gene mutations in primary human prostate cancer. Prostate, 27: 314-320, 1995.
11. Yoo, G., Xu, H., Brennan, J., Westra, W., Hruban, R., Koch, W., Benedict, W., and Sidransky, D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res., 54: 4603-4606, 1994.
12. Brown, A., Ross, F., Dunne, E., Steel, M., and Weir-Thompson, E. Evidence for a new tumor suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat. Genet., 3: 67-72, 1993.
13. Stilgenbauer, S., Leupolt, E., Ohl, S., Weis, G., Schroder, M., Fischer, K., Bentz, M., Lichter, P., and Dohner, H. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res., 55: 3475-3477, 1995.
14. Devilder, M., Francois, S., Bosic, C., Moreau, A., Mellerin, M., Le Paslier, D., Bataille, R., and Moisan, J. Deletion cartography around the D13S25 locus in B cell chronic lymphocytic leukemia and accurate mapping of the involved tumor suppressor gene. Cancer Res., 55: 1355-1357, 1995.
15. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., and Micklem, G. Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 378: 789-792, 1995.
16. Tulinius, H., Egilsson, V., Olafsdottir, G., and Sigvaldason, H. Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer. Br. Med. J., 305: 855-857, 1992.
17. Ittmann, M., Wieczorek, R., Heller, P., Dave, A., Provet, J., and Krolewski, J. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized stage B prostate adenocarcinomas. Am. J. Pathol., 145: 287-293, 1994.
18. Petrukhin, K., Speer, M., Cayanis, E., Bonaldo, M., Tantravahi, U., Soares, M., Fischer, S., Warburton, D., Gilliam, T., and Ott, J. A microsatellite linkage map of human chromosome 13. Genomics, 15: 76-85, 1993.
19. Bowcock, A., Osborne-Lawrence, S., Barnes, R., Chakravarti, A., Washington, S., and Dunn, C. Microsatellite polymorphism linkage map of human chromosome 13q. Genomics, 15: 376-386, 1993.
20. MacGrogan, D., Levy, A., Bostwick, D., Wagner, M., Wells, D., and Bookstein, R. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer, 10: 151-159, 1994.
21. Hamann, U., Herbold, C., Costa, S., Solamayer, E., Kaufmann, M., Bastert, G., Ulmer, H., Frenzel, H., and Komitowski, D. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res., 56: 1988-1990, 1996.
22. Bookstein, R., Shew, J., Chen, P., Scully, P., and Lee, W. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science (Washington DC), 247: 712-715, 1989.
23. Geradts, J., Kratzke, R., Crush-Stanton, S., Wen, S., and Lincoln, C. Wild-type and mutant retinoblastoma protein in paraffin sections. Mod. Pathol., 9: 339-347, 1996.